<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font29 { font-size : 29; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font29">and </span>
   <span class="font17">with </span>
   <span class="font17">was </span>
   <span class="font16">were </span>
   <span class="font15">for </span>
   <span class="font14">The </span>
   <span class="font14">antiviral </span>
   <span class="font14">{background </span>
   <span class="font14">against </span>
   <span class="font13">SARS-CoV- </span>
   <span class="font13">drug </span>
   <span class="font13">margin </span>
   <span class="font12">potential </span>
   <span class="font12">{border-style </span>
   <span class="font12">are </span>
   <span class="font12">lumefantrine </span>
   <span class="font12">px;} </span>
   <span class="font12">#ffffff;} </span>
   <span class="font12">viral </span>
   <span class="font12">cells </span>
   <span class="font12">drugs </span>
   <span class="font12">have </span>
   <span class="font12">virus </span>
   <span class="font12">artesunate </span>
   <span class="font12">that </span>
   <span class="font11">anti-SARS-CoV- </span>
   <span class="font11">Î¼M, </span>
   <span class="font11">arteannuin </span>
   <span class="font11">artemisinins </span>
   <span class="font11">from </span>
   <span class="font11">treatment </span>
   <span class="font11">after </span>
   <span class="font11">artemisinin </span>
   <span class="font11">its </span>
   <span class="font11">performed </span>
   <span class="font11">reported </span>
   <span class="font11">which </span>
   <span class="font11">(CAS </span>
   <span class="font11">No. </span>
   <span class="font11">different </span>
   <span class="font11">showed </span>
   <span class="font11">R.; </span>
   <span class="font11">Vero </span>
   <span class="font11">could </span>
   <span class="font11">infection </span>
   <span class="font11">px; </span>
   <span class="font11">{font-family </span>
   <span class="font11">(Figure </span>
   <span class="font11">Antiviral </span>
   <span class="font11">COVID- </span>
   <span class="font11">Figure </span>
   <span class="font11">RNA </span>
   <span class="font11">Res., </span>
   <span class="font11">artemisinins, </span>
   <span class="font11">effects </span>
   <span class="font11">font-size </span>
   <span class="font11">plasma </span>
   <span class="font11">their </span>
   <span class="font10">--), </span>
   <span class="font10">A.; </span>
   <span class="font10">Arteannuin </span>
   <span class="font10">COVID-. </span>
   <span class="font10">EfferthT.; </span>
   <span class="font10">For </span>
   <span class="font10">analysis </span>
   <span class="font10">been </span>
   <span class="font10">broad-spectrum </span>
   <span class="font10">compounds </span>
   <span class="font10">double; </span>
   <span class="font10">human </span>
   <span class="font10">infected </span>
   <span class="font10">lumefantrine, </span>
   <span class="font10">pharmacokinetic </span>
   <span class="font10">protein </span>
   <span class="font10">selected </span>
   <span class="font10">using </span>
   <span class="font10">vitro </span>
   <span class="font10">After </span>
   <span class="font10">Artemisinins </span>
   <span class="font10">M.; </span>
   <span class="font10">PBPK </span>
   <span class="font10">S.; </span>
   <span class="font10">StammingerT.; </span>
   <span class="font10">Western </span>
   <span class="font10">added </span>
   <span class="font10">antimalarial </span>
   <span class="font10">approved </span>
   <span class="font10">assays </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">clinical </span>
   <span class="font10">coronavirus </span>
   <span class="font10">cytomegalovirus </span>
   <span class="font10">data </span>
   <span class="font10">doses </span>
   <span class="font10">effect </span>
   <span class="font10">effective </span>
   <span class="font10">experimental </span>
   <span class="font10">expression </span>
   <span class="font10">has </span>
   <span class="font10">inhibit </span>
   <span class="font10">malaria. </span>
   <span class="font10">mean </span>
   <span class="font10">oral </span>
   <span class="font10">population </span>
   <span class="font10">research </span>
   <span class="font10">serum </span>
   <span class="font10">solid; </span>
   <span class="font10">therapeutic </span>
   <span class="font10">vitro. </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">./s---. </span>
   <span class="font10">All </span>
   <span class="font10">Artesunate </span>
   <span class="font10">C.; </span>
   <span class="font10">H.; </span>
   <span class="font10">IFA </span>
   <span class="font10">J.; </span>
   <span class="font10">K.; </span>
   <span class="font10">L.; </span>
   <span class="font10">Med. </span>
   <span class="font10">This </span>
   <span class="font10">WolfD. </span>
   <span class="font10">Y.; </span>
   <span class="font10">according </span>
   <span class="font10">activities </span>
   <span class="font10">activity </span>
   <span class="font10">antibody, </span>
   <span class="font10">artemisone </span>
   <span class="font10">assay </span>
   <span class="font10">available </span>
   <span class="font10">based </span>
   <span class="font10">bold </span>
   <span class="font10">bovine </span>
   <span class="font10">candidates </span>
   <span class="font10">carried </span>
   <span class="font10">cell </span>
   <span class="font10">combination </span>
   <span class="font10">concentrations </span>
   <span class="font10">courier; </span>
   <span class="font10">dihydroartemisinin </span>
   <span class="font10">efficacy </span>
   <span class="font10">em; </span>
   <span class="font10">global </span>
   <span class="font10">including </span>
   <span class="font10">might </span>
   <span class="font10">model </span>
   <span class="font10">multiple </span>
   <span class="font10">other </span>
   <span class="font10">out </span>
   <span class="font10">over </span>
   <span class="font10">profile </span>
   <span class="font10">pt;} </span>
   <span class="font10">quantified </span>
   <span class="font10">results </span>
   <span class="font10">secondary </span>
   <span class="font10">shown </span>
   <span class="font10">six </span>
   <span class="font10">stages. </span>
   <span class="font10">stained </span>
   <span class="font10">studies </span>
   <span class="font10">such </span>
   <span class="font10">systematically </span>
   <span class="font10">there </span>
   <span class="font10">use </span>
   <span class="font10">when </span>
  </p>
 </body>
</html>
